Plain-English translation of NCT07300241 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is one of the first times this treatment has been tested in people.
This is an early-stage clinical trial testing a new medication called for people with advanced clear cell renal cell carcinoma (a type of kidney cancer) that has spread or cannot be surgically removed. Researchers want to find the right dose of this medication and understand how well it works for patients whose cancer has stopped responding to standard treatments. This is one of the first times this medication is being tested in humans.
Many patients with advanced kidney cancer eventually stop responding to current standard treatments, leaving them with limited options. This trial exists to test whether this new treatment approach might help patients whose cancer is no longer controlled by available therapies.
You likely qualify if…
You likely don't qualify if…
As a participant, you would take the study medication by mouth according to a dosing schedule that may increase over time as researchers determine the safest and most effective dose. You would visit the clinic regularly for blood tests, physical exams, and imaging scans to monitor how your cancer responds to the treatment and to check for side effects. The study is relatively small, enrolling about 30 people total, and your doctors will carefully watch your health throughout your participation.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
United States